|
Volumn 33, Issue 9, 2009, Pages
|
CD8+ memory T cells predominate over naïve T cells in therapy-free CML patients with sustained major molecular response
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
INTERFERON;
ADULT;
AGED;
CANCER RELAPSE;
CD8+ T LYMPHOCYTE;
CHRONIC MYELOID LEUKEMIA;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG RESPONSE;
DRUG WITHDRAWAL;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
LETTER;
LYMPHOCYTE COUNT;
MALE;
MEMORY T LYMPHOCYTE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
T LYMPHOCYTE;
UNSPECIFIED SIDE EFFECT;
ADULT;
AGED;
CD8-POSITIVE T-LYMPHOCYTES;
FEMALE;
HUMANS;
IMMUNOLOGIC MEMORY;
IMMUNOPHENOTYPING;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MALE;
MIDDLE AGED;
|
EID: 67549094666
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/j.leukres.2009.03.024 Document Type: Letter |
Times cited : (6)
|
References (7)
|